TECHNETIUM TC99M MEDRONATE Kit for the preparation Ref.[11056] Active ingredients: Technetium โนโนแตTc medronic acid

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

Diagnostic – For skeletal imaging description.

For Intravenous Use.

The kit consists of reaction vials which contain the sterile, non-pyrogenic,non-radioactive ingredients necessary to produce Technetium Tc 99m Medronate Injection for diagnostic use by intravenous injection. MDP-25 reaction vials are intended to be used as multidose vials.

Each 10 mL MDP-25 reaction vial contains 25.0 mg medronic acid and not less than 2.0 mg of stannous chloride dihydrate (maximum total tin expressed as stannous chloride dihydrate 3.0 mg) and 5.0 mg of p-aminobenzoic acid in lyophilized form under an atmosphere of nitrogen.

The pH is adjusted to 6.8 to 6.9 with HCI or NaOH prior to lyophilization. The addition of sterile, non-pyrogenic, and oxidant-free sodium pertechnetate Tc-99m sterile solution produces a rapid labeling which is essentially quantitative and which remains stable in vitro throughout the 12-hours life of the preparation. No bacteriostatic preservative is present.

The structural formula of medronic acid is:

Physical characteristics

Technetium Tc-99m decays by isomeric transition with a physical half-life of 6.02 hours. 1 The principal photon that is useful for detection and imaging studies is listed in Table 1.

Table 1. Principal Radiation Emission Data:

Radiation Mean % / Disintegration Energy (keV)
Gamma-2 89.07 140.5

External radiation

The specific gamma ray constant for Tc-99m is 0.78 R/mCi-hr at 1 cm. The first half value layer is 0.017 cm of lead. To facilitate control of the radiation exposure from millicurie amounts of this radionuclide, the use of a 0.25 cm thickness of lead will attenuate the radiation emitted by a factor of about 1000. A range of values for the relative attenuation of the radiation emitted by this radionuclide that results from interposition of various thicknesses of lead is shown in Table 2.

Table 2. Radiation Attenuation by Lead Shielding:

Shield Thickness
(Pb) cm
Coefficient of Attenuation
0.0170.5
0.0810-1
0.1610-2
0.2510-3
0.3310-4

To correct for physical decay of this radionuclide, the fractions that remain at selected intervals after the time of calibration are shown in Table 3. 1Kocher, David C.: “Radioactive Decay Data Tables”, DOE/TIC-11026, 108 (1981)

Table 3. Physical Decay Chart: Tc-99m, half-life 6.02 hours:

Hours FractionRemaining Hours FractionRemaining
0* 1.00070.447
10.89180.398
20.79490.355
30.708100.316
40.631110.282
50.562120.251
60.501  

* Calibration time

How Supplied

MDP-25, Kit for the Preparation of Technetium Tc 99m Medronate Injection.

Product No. 500661 (30 vials).

Available in boxes consisting of 30 reaction vials, each vial containing in lyophilized form, sterile and non-pyrogenic:

Medronic Acid: 25.0 mg
Stannous Chloride Dihydrate (minimum): 2.0 mg
(Maximum tin as stannous chloride dihydrate): 3.0 mg
p-Aminobenzoic Acid: 5.0 mg

The pH is adjusted to 6.8 to 6.9 with HCI or NaOH prior to lyophilization. The vials are sealed under an atmosphere of nitrogen.

Radioassay information labels with radiation warning symbol and a package insert are supplied in each box.

Manufactured by: Jubilant DraxImage Inc., Kirkland Quebec, H9H 4J4 Canada

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.